Sally Parker

602 total citations
11 papers, 485 citations indexed

About

Sally Parker is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Sally Parker has authored 11 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 3 papers in Rheumatology. Recurrent topics in Sally Parker's work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Sally Parker is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Sally Parker collaborates with scholars based in United Kingdom, United States and Netherlands. Sally Parker's co-authors include Emmanuel Farber, Margot Gruenstein, Andrew Chase, John M. Goldman, Gary M. Williams, Nicholas C.P. Cross, Jaspal Kaeda, Syma Iqbal, Sarah Kulkarni and Christopher Pocock and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Journal of Medicinal Chemistry.

In The Last Decade

Sally Parker

10 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sally Parker United Kingdom	8	182	163	162	154	94	11	485
Chi-Chung Chan China	10	65 0.4×	155 1.0×	41 0.3×	100 0.6×	61 0.6×	24	414
Stuart Raaka United States	5	101 0.6×	88 0.5×	24 0.1×	75 0.5×	47 0.5×	5	430
Ellen M. van der Aar Netherlands	9	56 0.3×	172 1.1×	129 0.8×	96 0.6×	12 0.1×	14	553
Tokiko Nakamura Japan	7	165 0.9×	115 0.7×	35 0.2×	89 0.6×	27 0.3×	20	517
Aya Sakai Japan	10	129 0.7×	271 1.7×	24 0.1×	87 0.6×	104 1.1×	48	672
Cynthia Serdikoff United States	8	118 0.6×	154 0.9×	130 0.8×	176 1.1×	16 0.2×	9	472
Ganji Kuroiwa Japan	7	120 0.7×	115 0.7×	36 0.2×	41 0.3×	22 0.2×	14	492
C. Brindley United Kingdom	11	22 0.1×	322 2.0×	49 0.3×	30 0.2×	65 0.7×	14	523
Xuelan Zuo China	9	60 0.3×	262 1.6×	24 0.1×	49 0.3×	136 1.4×	25	516
Diane M. Pierson United States	9	32 0.2×	111 0.7×	37 0.2×	40 0.3×	21 0.2×	11	324

Countries citing papers authored by Sally Parker

Since Specialization

Citations

This map shows the geographic impact of Sally Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Parker more than expected).

Fields of papers citing papers by Sally Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Parker. The network helps show where Sally Parker may publish in the future.

Co-authorship network of co-authors of Sally Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Parker. A scholar is included among the top collaborators of Sally Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Parker. Sally Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hasserjian, Robert P., Sally Parker, Andrew Chase, et al.. (2002). STI571 (Imatinib Mesylate) Reduces Bone Marrow Cellularity and Normalizes Morphologic Features Irrespective of Cytogenetic Response. American Journal of Clinical Pathology. 117(3). 360–367. 52 indexed citations

Sohal, Jastinder, Andrew Chase, Sarah Mould, et al.. (2001). Identification of four new translocations involving FGFR1 in myeloid disorders. Genes Chromosomes and Cancer. 32(2). 155–163. 67 indexed citations

Marley, Stephen B., Richard J. Davidson, John L. Lewis, et al.. (2001). Progenitor cells from patients with advanced phase chronic myeloid leukaemia respond to STI571 in vitro and in vivo. Leukemia Research. 25(11). 997–1002. 9 indexed citations

Kulkarni, Sarah, Sally Parker, Andrew Chase, et al.. (2000). Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21).. PubMed. 60(13). 3592–8. 92 indexed citations

Chase, Andrew, et al.. (2000). Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia. Blood. 96(2). 777–778. 6 indexed citations

Olavarría, Eduardo, Sally Parker, Charles Craddock, et al.. (2000). Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.. PubMed. 85(6). 647–52. 4 indexed citations

Chase, Andrew, et al.. (2000). Absence of host-derived cells in the blood of patients in remission after allografting for chronic myeloid leukemia. Blood. 96(2). 777–778. 7 indexed citations

Parker, Sally & William S. Brinigar. (1976). Synthesis of a hemin with structurally equivalent propionic acid side chains: 2,4-dimethyldeuterohemin IX dimethyl ester. Bioinorganic Chemistry. 5(4). 325–327. 2 indexed citations

Farber, Emmanuel, Sally Parker, & Margot Gruenstein. (1976). The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens.. PubMed. 36(11 Pt 1). 3879–87. 166 indexed citations

10.

Williams, Gary M., et al.. (1976). Nature of Early Appearing, Carcinogen-Induced Liver Lesions Resistant to Iron Accumulation 2 3. JNCI Journal of the National Cancer Institute. 57(1). 157–165. 67 indexed citations

11.

Parker, Sally & Joseph Weinstock. (1973). Biotransformation of 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridinedicarboxylic acid diethyl ester. Journal of Medicinal Chemistry. 16(1). 34–37. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact